To reveal the role of LINC00162 and sorafenib treatment in regulating the stemness of thyroid cancer cells, we evaluated the expression of SOX2, NANOG, CD133, and CD44 in B-CPAP cancer cells. Here, CD44 is linked to thyroid cancer.